What is Solution21?
Solution21, operating as Radiation Oncology Specialists of Central Virginia, occupies a critical niche in the medical services landscape. The company specializes in advanced cancer diagnosis and therapeutic interventions, including Stereotactic Body Radiation Therapy and Prostate Brachytherapy. By leveraging board-certified expertise and cutting-edge medical technology, the firm provides non-invasive, clinically validated care pathways. Their dual-facility presence in central Virginia serves as a cornerstone for their mission to enhance patient outcomes through personalized, evidence-based oncology protocols.
How much funding has Solution21 raised?
Solution21 has raised a total of $92K across 1 funding round:
Debt
$92K
Debt (2021): $92K with participation from PPP
Key Investors in Solution21
PPP
Public-Private Partnership
What's next for Solution21?
The infusion of capital is expected to accelerate the firm's operational capacity and technological integration. As the company navigates its current Series B/C stage, the focus will likely shift toward expanding its diagnostic capabilities and optimizing patient throughput. By reinvesting this financing into advanced radiotherapy infrastructure, Solution21 aims to solidify its market position as a premier provider of oncology services, ensuring that patients receive state-of-the-art care while the organization achieves long-term financial sustainability and clinical excellence.
See full Solution21 company page
